CVE-2025-3423 | BDVDB-2026-274643 Detail

IBMAspera Faspex

Description#

IBM Aspera Faspex 5.0.0 through 5.0.11 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Impact#

Per CVSS v3.1: confidentiality impact low, integrity impact low, availability impact none. Attack vector: network.

Weaknesses#

CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

References#

https://www.ibm.com/support/pages/node/7230757

Exploit#

No public exploit known

History#

Version 12025-04-13Record published in the CVE List.
Version 22025-09-01Most recent update recorded in the CVE List.

Published

Published: 2025-04-13
Last modified: 2025-09-01

Vendor information

Vendor: IBM
Product: Aspera Faspex

All IBM vulnerabilities

Score

5.4 Medium

EPSS

less than 1%, Very Low

Estimated chance of exploitation in the next 30 days. EPSS percentile: 21.4.

KEV

Not listed in the CISA Known Exploited Vulnerabilities catalog.

Impact

Cross-Site Scripting

Action

No specific action is recorded in the source data. Check the references for vendor guidance.

Affected Systems

Vulnerable
>= 5.0.0 and <= 5.0.11
Fixed
Not stated

Scoring System

CVSS v4.0

Not available

CVSS v3.1

5.4 Medium

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Metric breakdown
Attack Vector	Network
Attack Complexity	Low
Privileges Required	Low
User Interaction	Required
Scope	Changed
Confidentiality	Low
Integrity	Low
Availability	None

CVSS v3.0

Not available

CVSS v2

Not available

Source: CVE List v5 (record); CISA KEV (kev, action); FIRST EPSS (epss).